The invention disclosed herein is a novel liquid pharmaceutical composition comprising a combination of Sucralfate, a gastrointestinal medication and Domperidone a peripheral dopamine receptor antagonist along with pharmaceutically acceptable exicipients useful for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal disorders.